Evaluation of clinical application of salvianolate for injection
10.3760/cma.j.issn.1008-6706.2020.10.011
- VernacularTitle:注射用丹参多酚酸盐的临床应用评价
- Author:
Qinqin ZHAO
1
;
Lisong LYU
;
Yanhua CHEN
;
Chengle LI
;
Bingqing LIANG
;
Wenjuan YANG
Author Information
1. 浙江省立同德医院药学部，杭州 310012
- From:
Chinese Journal of Primary Medicine and Pharmacy
2020;27(10):1198-1202
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical application of salvianolate for injection in Tongde Hospital of Zhejiang Province and evaluate its rationality of injection.Methods:From March 2018 to November 2018, 560 patients treated with salvianolate for injection in Tongde Hospital of Zhejiang Province were selected by random sampling method.The indications, usage and dosage, route of administration, choice of vehicle, concentration of vehicle, course of treatment, compatibility, contraindications and adverse reactions of salvianolate for injection were analyzed retrospectively.Results:Totally 560 inpatients received salvianolate for injection were collected, about 26.96%(151/560) was consistent with the indication, 99.82%(559/560) with a correct administration dosage and frequency, 100.00%(560/560) with right administration route, 95.00%(532/560) with a right solvent selection, 67.86%(380/560) with correct solvent concentration, 61.07%(342/560) with a correct treatment course, 100.00%(560/560) with a right medicine combination, about 94.46%(529/560) was consistent with coagulation function contraindication, about 90.18%(505/560) was consistent with liver function contraindication.The incidence of adverse reactions was 1.61%(9/560).Conclusion:In the clinical application of salvianolate for injection, a high rate of unreasonable usage is found in indication, treatment course and solvent selection.Because of the serious problems in the use of salvianolate injection, it should be used strictly to ensure clinical medication safety.
